基于临床研究文献的数据挖掘分析中医药预防卵巢子宫内膜异位囊肿术后复发的用药规律
Traditional Chinese Medicine for Preventing Postoperative Recurrence of Ovarian Endometriotic Cysts: A Data Mining Analysis of Clinical Studies
DOI: 10.12677/acm.2026.1693177, PDF,   
作者: 尹佳丽:成都中医药大学临床医学院,四川 成都;季晓黎*:成都中医药大学附属医院妇科,四川 成都
关键词: 卵巢子宫内膜异位囊肿;术后复发;中医药;数据挖掘;活血化瘀;Ovarian Endometriotic Cyst; Postoperative Recurrence; Traditional Chinese Medicine; Data Mining; Blood-Activating and Stasis-Resolving Therapy
摘要: 目的:基于数据挖掘技术探究中医药预防卵巢子宫内膜异位囊肿(ovarian endometriotic cyst, OEC)术后复发的临床用药规律,为临床优化防治方案提供依据。方法:检索中国知网(CNKI)、万方数据知识服务平台(Wanfang Data)、维普数据库(VIP)和中国生物医学文献服务系统(SinoMed)从建立数据库至2026年7月12日收录的中医药预防OEC术后复发相关临床研究文献。经筛选、处方提取和数据标准化后,采用古今医案云平台(V3.0)进行药物频次统计、四气五味、归经、功效、关联规则、聚类分析及复杂网络分析。结果:纳入合格文献59篇,涉及中药处方59首、中药127味,累计用药频次680次。高频药物依次为当归、赤芍、川芎、延胡索、莪术等;药性以温、平、微寒为主,药味集中于辛、甘、苦,归经主要涉及肝、脾、肾、心经。功效以调经止痛为主。关联规则分析获得20条满足设定条件的有向关联规则,聚类分析得到4类核心配伍模块,复杂网络分析显示当归、赤芍、川芎、莪术、丹参等为核心节点药物。结论:OEC术后复发相关处方以活血化瘀药为基础,并兼顾补肾益气、疏肝理气等治法,体现扶正祛邪、攻补兼施的组方特点。本研究结果可为临床处方优化及后续研究提供参考,但核心药物组合的复发预防作用仍需通过前瞻性临床研究进一步验证。
Abstract: Objective: To investigate the prescription patterns of traditional Chinese medicine (TCM) used to prevent postoperative recurrence of ovarian endometriotic cyst (OEC) through data mining and to provide a reference for optimizing clinical prevention and treatment strategies. Methods: The CNKI, Wanfang Data, VIP, and SinoMed databases were searched from inception to July 12, 2026, for clinical studies evaluating TCM, either alone or in combination with conventional Western medicine, for the prevention of postoperative recurrence of OEC. After study selection, prescription extraction, and data standardization, analyses of drug frequency, four qi, five flavors, meridian tropism, medicinal functions, association rules, cluster analysis, and complex networks were conducted using the Ancient and Modern Medical Case Cloud Platform (V3.0). Results: Fifty-nine eligible studies were included, involving 59 TCM prescriptions containing 127 medicinal substances, with a total of 680 drug occurrences across all prescriptions. The most frequently used medicines were Angelicae sinensis Radix, Paeoniae Radix Rubra, Chuanxiong Rhizoma, Corydalis Rhizoma, and Curcumae Rhizoma. The medicinal properties were predominantly warm, neutral, and slightly cold, while the main flavors were pungent, sweet, and bitter. The main meridian tropisms were the liver, spleen, kidney, and heart meridians. The most frequently observed medicinal functions were menstrual regulation and pain relief. Association rule analysis identified 20 directed association rules that met the specified support and confidence thresholds. Cluster analysis yielded four core compatibility modules, and complex network analysis identified Angelicae sinensis Radix, Paeoniae Radix Rubra, Chuanxiong Rhizoma, Curcumae Rhizoma, and Salviae miltiorrhizae Radix et Rhizoma as centrally positioned medicines in the co-occurrence network. Conclusion: TCM prescriptions used to prevent postoperative recurrence of OEC were primarily based on blood-activating and stasis-resolving medicines, with additional emphasis on tonifying the kidney and qi and soothing the liver while regulating qi. These findings reflect a balanced therapeutic strategy that combines tonification and elimination. The results may provide a reference for optimizing clinical prescriptions and informing subsequent research. However, the preventive effects of the identified core medicine combinations on postoperative recurrence require further validation in prospective clinical studies.
文章引用:尹佳丽, 季晓黎. 基于临床研究文献的数据挖掘分析中医药预防卵巢子宫内膜异位囊肿术后复发的用药规律[J]. 临床医学进展, 2026, 16(9): 1390-1403. https://doi.org/10.12677/acm.2026.1693177

参考文献

[1] Yilmaz Hanege, B., Güler Çekiç, S. and Ata, B. (2019) Endometrioma and Ovarian Reserve: Effects of Endometriomata Per Se and Its Surgical Treatment on the Ovarian Reserve. Facts, Views and Vision in ObGyn, 11, 151-157.
[2] 中国中西医结合学会妇产科专业委员会. 子宫内膜异位症中西医结合诊治指南[J]. 中国中西医结合杂志, 2019, 39(10): 1169-1176.
[3] 肖红艳. 子宫内膜异位症腹腔镜术后GnRH-a结合反向添加疗法对疗效与安全性的影响[J]. 中国实用医药, 2021, 16(24): 47-50.
[4] 陈群. 加味归肾丸联合中药封包防治肾虚血瘀型卵巢子宫内膜异位囊肿术后复发的临床观察[D]: [硕士学位论文]. 长沙: 湖南中医药大学, 2025.
[5] 张保华, 徐红, 蒋春露, 等. 中药内异消联合GnRH-a对卵巢子宫内膜异位囊肿保守性术后保护卵巢功能的临床观察[J]. 医药论坛杂志, 2024, 45(18): 1993-1997.
[6] 国家药典委. 中华人民共和国药典 一部 2025年版[M]. 北京: 中国医药科学技术出版社, 2025.
[7] 钟赣生. 中药学[M]. 北京: 中国中医药出版社, 2016.
[8] 谢幸, 孔北华, 段涛. 妇产科学[M]. 北京: 人民卫生出版社, 2018.
[9] 彭超, 周应芳. 复发性卵巢子宫内膜异位症的管理[J]. 中国实用妇科与产科杂志, 2022, 38(5): 491-495.
[10] 闫金雨. 活血化瘀祛湿汤在卵巢巧克力囊肿术后的应用[J]. 中国中医药科技, 2019, 26(5): 754-756.
[11] 梁雪芳, 向东方. 中医药综合疗法干预与子宫内膜异位症盆腔状况87例分析[J]. 陕西中医, 2006(6): 672-673.
[12] 程红, 陈梦娜. 梁文珍教授经验方在卵巢子宫内膜异位囊肿腹腔镜术后管理中的应用[J]. 河北中医, 2025, 47(11): 1769-1772.
[13] 肖珊, 陈逸嘉, 赵莉, 等. 王大增应用化瘀通腑法治疗子宫内膜异位症经验[J]. 中医文献杂志, 2023, 41(5): 62-64.
[14] 李时珍. 本草纲目[M]. 南昌: 二十一世纪出版社, 2014.
[15] 孟繁词, 张天婵, 于洋, 等. 活血化瘀类中药治疗子宫内膜异位症作用机制的研究进展[J]. 湖南中医药大学学报, 2021, 41(8): 1307-1312.
[16] 康宁, 马素娟. 活血化瘀中药含药血清对子宫内膜异位症在位及异位内膜间质细胞生长及分泌Ang-2的影响[J]. 中国保健营养(中旬刊), 2012(9): 33-34.
[17] 穆兰澄, 顾成娟, 徐立鹏, 等. 平性药药性及应用特点[J]. 中医杂志, 2017, 58(1): 23-26, 45.
[18] 张仲景. 伤寒论[M]. 广州: 广东科技出版社, 2022.
[19] 何飞武. 基于数据挖掘的苦味药在经方中的应用研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2017.
[20] 谦德书院. 黄帝内经·灵枢 下[M]. 北京: 团结出版社, 2024.
[21] 徐昕. 浅议情志因素与妇产科疾病[J]. 时珍国医国药, 2007(11): 2835-2836.
[22] 叶天士. 临证指南医案[M]. 北京: 中版集团数字传媒有限公司, 2021.
[23] 袁可欣, 谭艺, 张成玲, 等. 基于网络药理学和分子对接的“当归-川芎”药对作用机制研究[J]. 西南大学学报(自然科学版), 2021, 43(10): 77-83.
[24] 黄礼闯, 赵梦亭, 桑夏楠, 等. 三棱-莪术药对化学成分及药理作用研究进展[J]. 中华中医药杂志, 2021, 36(11): 6612-6616.
[25] 吕奇霏, 刘欣. 赤芍及其药对研究进展[J]. 临床合理用药, 2025, 18(28): 172-178.
[26] 张阳, 刘毅. 当归化学成分、药理作用、常见配伍及临床应用研究进展[J]. 河南中医, 2026, 46(6): 839-848.
[27] 邵璐彬. 不同配比赤芍-川芎药对配伍中11个成分提取率考察[J]. 中国药师, 2022, 25(1): 172-177.
[28] 顾俊菲, 封亮, 袁嘉瑞, 等. 赤芍总苷、川芎总酚酸组分组成结构对缺氧损伤人脐静脉内皮细胞的影响[J]. 中国中药杂志, 2015, 40(5): 920-926.
[29] 宗春晓, 徐信, 谢伟, 等. 基于网络药理学探讨三棱-莪术药对治疗子宫内膜异位症的作用机制[J]. 世界中医药, 2022, 17(11): 1553-1559.
[30] 曾荣, 曹保利, 李继坤. 补肾祛瘀方防治卵巢巧克力囊肿腹腔镜术后复发的观察[J]. 天津医科大学学报, 2011, 17(4): 563-564, 566.
[31] 王金平, 刘丽敏, 张立会, 等. 中药预防卵巢巧克力囊肿(气虚血瘀型)术后复发的临床研究[EB/OL].
https://kns.cnki.net/kcms2/article/abstract?v=14XpHnsxtHFEyfc4xZoVwoy2DrVHXoi7b8elGl2HUVQE-tWSSFnOAuLefb-2RD76-X_F8g-PAzJ-_cqmVB6ULIg-b6UgHQfQThPGUkddmv3L6SAL1MDYSxUAzaAW2mA1fAN48Zl8BKaoCKJLJKuyy5cKNB1yehKSSxPj9QI4yXAFZoyecPd24g==&uniplatform=NZKPT&language=CHS, 2021-12-10.
[32] 康文艳, 渠媛, 王静, 等. 补肾化瘀方加减对肾虚血瘀型子宫内膜异位症术后复发的预防作用与机制研究[J]. 天津中医药, 2024, 41(3): 294-298.
[33] Masferrer-Ferragutcasas, C., Delgado-Gil, R. and Colas, E. (2026) Rethinking Endometriosis Recurrence: From Clinical Challenge to Biological Opportunity. NPJ Women’s Health, 4, Article No. 4.
https://doi.org/10.1038/s44294-026-00128-9
[34] 王欢欢, 房志鑫, 王建彬, 等. 黄芪的主要化学成分及药理作用机制研究进展[J]. 黑龙江医学, 2026, 50(14): 1780-1782.
[35] 杨济瑜, 王颖. 淫羊藿活性成分对女性生殖内分泌调节作用的研究进展[J]. 陕西中医, 2026, 47(3): 420-423.
[36] 陈梁, 梁兆昌, 刘洋, 等. 基于网络药理学和分子对接技术的淫羊藿和杜仲雄花药对抗疲劳作用机制研究[J]. 井冈山大学学报(自然科学版), 2024, 45(5): 65-72.
[37] 郜艳雪, 时坤, 李健明, 等. 党参多糖对动物免疫调节作用研究进展[J]. 动物医学进展, 2019, 40(9): 103-106.
[38] 王琦, 宋芳, 应康, 等. 菟丝子对雌性生殖系统保护作用的研究进展[J]. 包头医学院学报, 2021, 37(9): 117-119.